Alzheimer's Disease: Experts discuss impacts, benefits and drawbacks of new drug
Trial studies on Lecanemab, a new investigational drug for the treatment of Alzheimer’s Disease, have shown it to moderately slow down cognitive and functional decline among early-stage patients. Doctors help decode the impact, benefits and possible drawbacks